Studies on the development of spectrophotometric method for the determination of haloperidol in pharmaceutical preparations

Quimica Nova

Volumn 35, Issue 2, 2012, Pages 392-397

  Rahman, Nafisur ^a   Khatoon, Asma ^a   Rahman, Habibur ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Haloperidol; Ion pair complex; Spectrophotometry

Indexed keywords

EID: 84859988524     PISSN: 01004042     EISSN: 16787064     Source Type: Journal    
DOI: 10.1590/S0100-40422012000200028     Document Type: Article

References (32)

1. Gilbert, M. M.; Curr. Ther. Res. 1969, 11, 520.
2. Hollister, L. E.; Basic and Clinical Pharmacology, 6th ed., Prentice-Hall: London, 1995, p. 432.
3. Singh, O. P.; Chakraborty, I.; Dasgupta, A.; Datta, S. A.; Indian J. Psychiatry 2008, 50, 171.
4. Cesario, V.; Recent Prog. Med. 2008, 99, 146.
5. Wate, S. P.; Bosker, A. A.; Int. J. ChemTech. Res. 2009, 1, 675.
6. Ali, I.; Aboul-Enien, H. Y.; J. Liq. Chromatogr. Relat. Technol. 2005, 28, 3169.
7. Petkovska, R.; Dimitrovska, A.; Acta Pharm. 2008, 58, 243.
8. Mennickent, S.; Pino, L.; Vega, M.; Godoy, C. G.; De-Diego, M.; J. Sep. Sci. 2007, 30, 772.
9. Mennickent, S.; Pino, L.; Vega, M.; Diego, M.; J. Sep. Sci. 2008, 31, 201.
10. Maslanka, A.; Krzek, J.; J. AOAC Int. 2005, 88, 70.
11. Shamsipur, M.; Shafiee-Dastgerdi, L.; Telebpour, Z.; Haghgoo, S.; J. Pharm. Biomed. Anal. 2007, 43, 1116.
12. El- Desoky, H. S.; Ghoneim, M. M.; J. Pharm. Biomed. Anal. 2005, 38, 543.
13. Ribeiro, F. W. P.; Soares, J. E. S.; Becker, H.; De-Souza, D.; de Lima- Neto, P.; Correia, A. N.; Electrochim. Acta 2011, 56, 2036.
14. Huang, F.; Peng, Y.; Jin, G.; Zhang, S.; Kong, J.; Sensors 2008, 8, 1879.
15. Kurzawa, M.; Kowalezyk-Marzec, A.; Szlyk, E.; Chem. Anal. 2004, 49, 91.
16. Rahman, N.; Siddiqui, S.; Drug Test. Anal. 2010, 2, 252.
17. European Pharmacopoeia; Council of Europe: Strasbourg, 2002, p. 1288.
18. Chinese Pharmacopoeia; Chinese Pharmacopoeia Commission, Chemical Industry Press: Beijing, 2005, p. 469.
19. Nagaraja, P.; Shrestha, A. K.; Shivakumar, A.; Al-Tayar, N. G. S.; Gowda, A. K.; Quim. Nova 2011, 34, 373.
20. Rufino, J. L.; Weinert, P. L.; Pezza, H. R.; Pezza, L.; Quim. Nova 2009, 32, 1764.
21. Önal, A.; Quim. Nova 2011, 34, 677.
22. Attama, A. A.; Nnamani, P. O.; Adikwu, M. U.; Akidi, F. O.; Chem. Pharm. Bull. 2004, 52, 303.
23. Shingbal, D. M.; Joshi, S. V.; Indian Drugs 1985, 22, 326.
24. Wate, S. P.; Borkar, A. A.; Indian J. Pharm. Sci. 2010, 72, 265.
25. Stolarczyk, M.; Apola, A.; Krzek, J.; Sajdak, A.; Acta Pol. Pharm. 2009, 66, 351.
26. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology, Q2(R 1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.
27. Skoog, D. A.; West, D. M.; Holler, F. J.; Crouch, S. R.; Fundamentals of Analytical Chemistry, 8th ed., Thomson and Brooks: California, 2004.
28. Schwarzenbach, G.; Biedermann, W.; Helv. Chim. Acta 1948, 31, 678.
29. Welcher, W. J.; The Analytical use of Ethylenediamine Tetraacetic Acid, 1st ed., D. van Nostrand Company, Inc.: New York, 1958.
30. Al Omari, M. M.; Zughul, M. B.; Devies, J. E. D.; Badwan, A. A.; J. Solution Chem. 2009, 38, 669.
31. Hartman, C.; Smeyers-Verbeke, J.; Pinninckx, W.; Heyden, Y. V.; Vankeerberghen, P.; Massart, D. L.; Anal. Chem. 1995, 67, 4491.
32. Canada Health Protection Branch, Ministry of National Health and Welfare; Acceptable Methods in Drugs Directorate Guidelines, Draft: Ottawa, 1992.